---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-010552"
form_type: "8-K"
ticker: "CLB"
cik: "0001958086"
company_name: "Core Laboratories Inc. /DE/"
filed_at: "2025-01-29T23:59:59+00:00"
generated_at: "2026-05-27T07:27:43.846138+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Core Lab Q4 revenue $129.2M, EPS $0.15; FY revenue $523.8M up 3%, free cash flow $43.4M up 200%

## Summary
- Q4 2024 revenue $129.2M (down 4% sequentially, up slightly YoY); GAAP EPS $0.15; ex-items EPS $0.22 (down 12% sequentially, up 16% YoY).
- Q4 operating income ex-items $15.7M (down 14% sequentially, up 4% YoY) with margins of 12%.
- Q4 free cash flow $16.2M (up over 50% sequentially); net debt reduced $11.7M; leverage ratio 1.31.
- FY 2024 revenue $523.8M (up 3%); ex-items operating income $65.3M (up 7%); ex-items EPS $0.87 (up 9%).
- Company repurchased 264,982 shares for $4.9M in Q4; declared $0.01/share dividend payable March 3, 2025.

## SEC filing metadata
- accession: 0000950170-25-010552
- form_type: 8-K
- ticker: CLB
- cik: 0001958086
- company_name: Core Laboratories Inc. /DE/
- filed_at: 2025-01-29T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1958086/000095017025010552/0000950170-25-010552-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1958086/000095017025010552/clb-20250129.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-010552
- JSON: https://secwatch.observer/filing/0000950170-25-010552.json
- Plain text: https://secwatch.observer/filing/0000950170-25-010552.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.